DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Frequency defined:  

>10% 

Nasal pharyngitis 

1-10% 

Back pain 

Cough 

≤3% 

Atrial fibrillation 

Bronchospasm 

Dizziness 

Dehydration 

Epistaxis 

Laryngitis 

Rash 

Constipation 

Urinary retention 

Dysuria 

Urticaria 

Pregnancy consideration: Insufficient data is available 

Lactation: Excretion of the drug is not known 

 

Pregnancy category: 

• Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester. 
• Category B: There is no evidence of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women. 
• Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women 
• Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits. 
• Category X: Drugs listed in this category outweigh the risks over benefits. These category drugs should be prohibited for pregnant women. 
• Category N: No data is available for the drug under this category. 

 

Patient information leaflet 

Generic Name: Olodaterol and tiotropium 

Pronounced: [ OH-loe-DAT-er-ol-and-TYE-oh-TROE-pee-um] 

Why do we use Olodaterol and tiotropium? 

It is used to treat and prevent lung disease symptoms (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema) such as wheezing and shortness of breath